Kabra Drugs Ltd

📊 Kabra Drugs Ltd: No Share Issuance in Q3 FY2026

• Kabra Drugs Limited confirms SEBI Regulation 32 does not apply for the quarter ended December 31, 2025.

• The company did not issue any shares through public, rights, or preferential issues during this quarter.

• No statements on deviations in fund usage or category-wise variations in fund utilization are required.

• Certification provided by Mr. Nanjappan Aravind, Managing Director (DIN: 01895602).